)

PharmaCorp Rx (PCRX) investor relations material
PharmaCorp Rx Q2 2025 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.
Executive summary
Operates as a national pharmacy consolidator with exclusive right-of-first-refusal on 1,100+ PharmaChoice Canada stores, focusing on acquisition-led growth and expanding its national footprint.
Demonstrates strong acquisition pipeline, positive net income in Q1-25, and a scalable platform through strategic alliances.
Management team with deep expertise in pharmacy, retail, and acquisitions, driving operational and financial performance.
Q2 2025 saw continued operational momentum, with growth in prescription volumes and front-of-store sales from three operating pharmacies.
Acquisition of a fourth pharmacy in Western Canada post-quarter-end furthered national scale ambitions.
Financial highlights
Q2-25 Adjusted EBITDA (Pre-IFRS 16, 4-Wall basis) was $688K, compared to $707K in Q1-25.
Same store script count grew 3.5% and same store sales increased 11.3% in Q2-25.
Maintains a strong balance sheet with $9.6M in cash and low leverage as of June 30, 2025.
Net loss for the quarter was driven by continued investment in corporate infrastructure and catch-up of deferred executive compensation from 2024.
Solid pharmacy-level contribution margins and consistent weighted average EBITDA multiples across acquisitions support the accretive growth model.
Outlook and guidance
Expects continued acquisition-driven growth, leveraging exclusive access to a large, fragmented market.
Pipeline includes 40+ new stores annually joining the PCC banner, with 40-50 stores turning over each year.
Anticipates further value creation through operational improvements and integration of acquired stores.
Management expects to close additional acquisitions in the second half of 2025, advancing previously announced pipeline transactions.
Focus remains on sourcing high-quality pharmacies that align with long-term acquisition strategy and contribute to accretion.
Next PharmaCorp Rx earnings date

Next PharmaCorp Rx earnings date

The essential earnings season companion
The #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
)
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
)
I can't remember the last time an app had such a positive impact on my investment process.
)
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
)
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
)
I can't remember the last time an app had such a positive impact on my investment process.
)
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
)
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
)
)
)
)
Frequently asked questions
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Explore our global coverage